Welcome to LookChem.com Sign In|Join Free

CAS

  • or

21082-33-7

Sakakin is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

21082-33-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • (2R,3S,4S,5R)-2-(hydroxymethyl)-6-(3-hydroxy-5-methylphenoxy)oxane-3,4,5-triol

    Cas No: 21082-33-7

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 21082-33-7 Structure

  • Basic information

    1. Product Name: Sakakin
    2. Synonyms: Orcinol glucoside;Orcinol β-D-glucopyranoside;Orcinol β-D-glucoside;Orcinol-3-O-β-D-glycopyranoside;1-O-beta-D-Glucosylorcinol;beta-D-Glucopyranoside 3-hydroxy-5-methylphenyl;Orcinol beta-D-glucopyranoside;Orcinol beta-D-glucoside
    3. CAS NO:21082-33-7
    4. Molecular Formula: C13H18O7
    5. Molecular Weight: 286.27782
    6. EINECS: N/A
    7. Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Inhibitors
    8. Mol File: 21082-33-7.mol

  • Chemical Properties

    1. Melting Point: 138 °C(Solv: methanol (67-56-1); ethanol (64-17-5))
    2. Boiling Point: 570.6±50.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.497
    6. Refractive Index: N/A
    7. Storage Temp.: ?20°C
    8. Solubility: N/A
    9. PKA: 9.55±0.10(Predicted)
    10. CAS DataBase Reference: Sakakin(CAS DataBase Reference)
    11. NIST Chemistry Reference: Sakakin(21082-33-7)
    12. EPA Substance Registry System: Sakakin(21082-33-7)

  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36
    3. Safety Statements: 26
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 21082-33-7(Hazardous Substances Data)

21082-33-7 Usage

Uses

Orcinol Glucoside produces antidepressant effects blocking behavioural and neuronal deficits.

Check Digit Verification of cas no

The CAS Registry Mumber 21082-33-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,0,8 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 21082-33:
(7*2)+(6*1)+(5*0)+(4*8)+(3*2)+(2*3)+(1*3)=67
67 % 10 = 7
So 21082-33-7 is a valid CAS Registry Number.

21082-33-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3S,4S,5R)-2-(hydroxymethyl)-6-(3-hydroxy-5-methylphenoxy)oxane-3,4,5-triol

1.2 Other means of identification

Product number -
Other names Orcinol glucoside

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21082-33-7 SDS

21082-33-7Downstream Products

21082-33-7Relevant articles and documents

Preparation method for orcinol glucoside

-

Paragraph 0035-0043, (2020/06/20)

The invention relates to a preparation method for orcinol glucoside. The preparation method comprises the following steps: allowing orcinol to react with different substituted acetylated glucose underthe action of proper acid or alkali so as to obtain orcinol tetraacetylated glucoside, and deacetylating the orcinol tetraacetylated glucoside under an alkaline condition so as to obtain the orcinolglucoside.

PHENOL GLYCOSIDES AND THEIR USE IN THE TREATMENT OF UROLITHIASIS

-

Page/Page column 26; 27; 28, (2017/01/26)

The present invention relates to novel derivatives of polyphenol glycoside or polyalcohols of formula (1), wherein R1, R2, R3 is selected from the group consisting of H, OH, C(O)R4, C(0) OR4, 0 (Gly H3)n, wherein n = 0 1, 2, 3, and R4 is selected from the group consisting of H, alkyl, and Gly is a mono- or disaccharide residue. The present invention also relates to novel derivatives of glycoside polyphenols or polyalcohols, as pharmaceutical composition comprising a novel polyphenol glycoside or polyalcohols and the use of novel polyphenol glycoside or polyalcohols for the treatment of urolithiasis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21082-33-7